This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Galena Biopharma Inc (GALE)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 23.65M 47.79M 32.81M 11.43M
Receivables 1.84M 3.68M 0.00 0.00
Inventories 655.00K 386.00K 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 29.02M 53.46M 36.12M 11.81M
Property, Plant & Equipment, Gross 555.00K 665.00K 48.00K 1.05M
Accumulated Depreciation & Depletion 0.00 0.00 19.00K 657.00K
Property, Plant & Equipment, Net 555.00K 665.00K 29.00K 393.00K
Intangibles 44.75M 27.84M 12.86M 12.86M
Other Non-Current Assets 87.00K 115.00K 74.00K 3.00K
Total Non-Current Assets 51.46M 34.52M 18.86M 19.16M
Liabilities & Shareholder Equity
Total Assets 80.49M 87.98M 54.99M 30.97M
Accounts Payable 2.27M 2.66M 1.98M 2.16M
Short Term Debt 3.91M 2.16M 6.00K 35.00K
Other Current Liabilities 5.38M 48.96M 11.90M 5.53M
Total Current Liabilities 27.23M 62.45M 15.92M 11.20M
Long Term Debt 4.49M 7.74M 0.00 0.00
Deferred Income Taxes 5.05M 5.05M 5.05M 5.05M
Other Non-Current Liabilities 6.65M 6.82M 6.21M 4.57M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 16.20M 19.64M 11.31M 9.65M
Total Liabilities 43.43M 82.09M 27.23M 20.86M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 37.06M 5.89M 27.76M 10.11M
Common Par 12.00K 10.00K 8.00K 5.00K
Additional Paid In Capital 256.38M 188.60M 132.17M 81.18M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -215.48M -178.88M -102.20M -67.23M
Treasury Stock -3.85M -3.85M -3.85M -3.85M
Other Equity Adjustments 0.00 0.00 1.63M 0.00
Total Capitalization 41.55M 13.63M 27.76M 10.11M
Total Equity 37.06M 5.89M 27.76M 10.11M
Total Liabilities & Stock Equity 80.49M 87.98M 54.99M 30.97M
Total Common Shares Outstanding 129.47M 109.43M 82.92M 47.14M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 675.00K 675.00K 675.00K 675.00K
Basic Weighted Shares Outstanding 119.39M 90.18M 62.48M 36.33M
Diluted Weighted Shares Outstanding 119.39M 90.18M 62.48M 36.33M
Number of Employees 57 60 12 29
Number of Part-Time Employees 0 0 0 0

GALE Galena Biopharma Inc

Chart of GALE

Analysts Ratings for GALE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 1 1 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1

GALE Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs